Patent ID: 7160911

Claim:
A compound of the formula I wherein Ring A is (C 3 –C 8 )-cycloalkanediyl or (C 3 –C 8 )-cycloalkenediyl, wherein one or more carbon atoms in said (C 3 –C 8 )-cycloalkanediyl and (C 3 –C 8 )-cycloalkenediyl groups is optionally replaced by oxygen atoms; Ring B is a) phenyl; or b) (C 3 –C 8 )-cycloalkyl, an 8-, 9-, 10, 11-, 12-, 13- or 14-membered aromatic ring, or a 5-, 6-, 7-, 8-, 9-, 10-, 11- or 12-membered heteroaromatic ring optionally containing one, two, three or four heteroatoms selected from the group consisting of N, O and S; R1 is a) in the case where ring B is selected from a) above: SCF 3 , OCF 2 —CHF 2 , O-phenyl or O—(C 1 –C 6 )-alkyl-O—(C 1 –C 3 )-alkyl; b) in the case where ring B is selected from b) above: H, F, Cl, Br, OH, NO 2 , CF 3 , OCF 3 , OCF 2 —CF 3 , SCF 3 , OCF 2 —CHF 2 , O-phenyl, (C 1 –C 6 )-alkyl, O—(C 1 –C 6 )-alkyl or O—(C 1 –C 6 )-alkyl-O—(C 1 –C 3 )-alkyl; c) in the case ring B is selected from a) above and R4 is phenyl: (C 1 –C 6 )-alkyl or O—(C 1 –C 6 )-alkyl; R2 is H or CF 3 ; R4 is a) in the case where ring B is selected from a) above: phenyl; b) in the case where ring B is selected from b) above: H, F, Cl, Br, OH, NO 2 , CF 3 , OCF 3 , (C 1 –C 6 )-alkyl or O—(C 1 –C 6 )-alkyl; c) in the case ring B is selected from a) above and R1 is selected from a) above: (C 1 –C 6 )-alkyl; R5 is H, F, Cl, Br, OH, NO 2 , CF 3 , OCF 3 , (C 1 –C 6 )-alkyl or O—(C 1 –C 6 )-alkyl; R3 is H or (C 1 –C 6 )-alkyl; X is (C 1 –C 6 )-alkanediyl, wherein one or more carbon atoms in said (C 1 –C 6 )-alkanediyl group are optionally replaced by oxygen atoms; Y is (C 1 –C 6 )-alkanediyl, wherein one or more carbon atoms in said (C 1 –C 6 )-alkanediyl group are optionally replaced by oxygen atoms; and pharmaceutically acceptable salts thereof.